A case of an asthma patient receiving omalizumab during pregnancy

Japanese Journal of Allergology

Volumn 61, Issue 11, 2012, Pages 1683-1687

  Hirashima, Junko ^a   Hojo, Masayuki ^a   Iikura, Motoyasu ^a   Hiraishi, Yoshihisa ^a   Nakamichi, Shinji ^a   Sugiyama, Haruhito ^a   Kobayashi, Nobuyuki ^a   Kudo, Koichiro ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Asthma; Lactation; Omalizumab; Pregnancy

Indexed keywords

CORTICOSTEROID; OMALIZUMAB;

ADULT; ARTICLE; ASTHMA; CASE REPORT; CESAREAN SECTION; DISEASE CONTROL; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; JAPAN; LOW BIRTH WEIGHT; PREGNANCY; RISK FACTOR; SPONTANEOUS ABORTION;

ANTI-ASTHMATIC AGENTS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL, HUMANIZED; ASTHMA; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84871551994     PISSN: 00214884     EISSN: 13477935     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Vignola AM, Humbert M, Bousquet J, Boulet LP, Hedgecock S, Blogg M, et al. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergie asthma and persistent allergic rhinitis: SOLAR. Allergy 2004; 59: 709-17. (Pubitemid 38850345)
2. Postma DS. Gender differences in asthma development and progression. Gend Med 2007; 4 Suppl B: S133-46.
3. Corren J, Casale TB, Lanier B, Buhl R, Holgate S, Jimenez P. Safety and tolerability of omalizumab. Clin Exp Allergy 2009; 39 (6): 788-97.
4. Demissie K, Breckenridge MB, Rhoads GG. Infant and maternal outcomes in the pregnancies of asthmatic women. Am J Respir Crit Care Med 1998; 158: 1091-5. (Pubitemid 28489006)
5. Perlow JH, Montgomery D, Morgan MA, Towers CV, Porto M. Severity of asthma and perinatal outcome. Am J Obstet Gynecol 1992; 167: 963-7.
6. Murphy VE, Gibson PG, Giles WB, Zakar T, Smith R, Bisits AM, et al. Maternal asthma is associated with reduced female fetal growth. Am J Respir Crit Care Med 2003; 168: 1317-23.
7. Lu W, Zhao Z, Zhao Y, Yu S, Zhao Y, Fan B, et al. Over-expression of the bovine FcRn in the mammary gland results in increased IgG levels in both milk and serum of transgenic mice. Immunology 2007; 122: 401-8.